CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producingEscherichia colibacteraemia of urinary origin in Spain
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producingEscherichia colibacteraemia of urinary origin in Spain
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 8, Pages 2125-2130
Publisher
Oxford University Press (OUP)
Online
2016-07-21
DOI
10.1093/jac/dkw133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temporal Trends in Antimicrobial Resistance and Virulence-Associated Traits within the Escherichia coli Sequence Type 131 Clonal Group and ItsH30 andH30-Rx Subclones, 1968 to 2012
- (2014) Bente Olesen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli ST131, an Intriguing Clonal Group
- (2014) M.-H. Nicolas-Chanoine et al. CLINICAL MICROBIOLOGY REVIEWS
- The Clonal Distribution and Diversity of Extraintestinal Escherichia coli Isolates Vary According to Patient Characteristics
- (2013) Ritu Banerjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12)
- (2013) C. Horner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Epidemic of Extended-Spectrum- -Lactamase-Producing Escherichia coli ST131 Is Driven by a Single Highly Pathogenic Subclone, H30-Rx
- (2013) L. B. Price et al. mBio
- Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli
- (2012) Adriana Ortega et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States
- (2012) Yohei Doi et al. CLINICAL INFECTIOUS DISEASES
- Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance
- (2012) J.P. Horcajada et al. CLINICAL MICROBIOLOGY AND INFECTION
- Virulence Profiles of Bacteremic Extended-Spectrum β-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features
- (2012) Jesús Rodríguez-Baño et al. PLoS One
- The ClermontEscherichia coliphylo-typing method revisited: improvement of specificity and detection of new phylo-groups
- (2012) Olivier Clermont et al. Environmental Microbiology Reports
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain
- (2011) J. Blanco et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials
- (2010) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diversity of Escherichia coli Strains Producing Extended-Spectrum -Lactamases in Spain: Second Nationwide Study
- (2010) M. A. Diaz et al. JOURNAL OF CLINICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started